GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

 1,827.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 2,208.00p
  • 52 Week Low: 1,735.50p
  • Currency: UK Pounds
  • Shares Issued: 4,045.44m
  • Volume: 0
  • Market Cap: £73,910m
  • RiskGrade: 129
  • Beta: 0.00

Latest ShareCast News

GSK Q3 sales rise as specialty medicines drive growth

By Benjamin Chiou

Date: Wednesday 28 Oct 2026

(Sharecast News) - GSK reported a 5% increase in third-quarter sales on Wednesday, driven by strong growth in specialty medicines, as the pharmaceutical giant reaffirmed its full-year guidance.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,827.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 2,208.00p
52 Week Low 1,735.50p
Volume 0
Shares Issued 4,045.44m
Market Cap £73,910m
Beta 0.00
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
78.37% below the market average78.37% below the market average78.37% below the market average78.37% below the market average78.37% below the market average
7.32% above the sector average7.32% above the sector average7.32% above the sector average7.32% above the sector average7.32% above the sector average
Price Trend
75.05% above the market average75.05% above the market average75.05% above the market average75.05% above the market average75.05% above the market average
67.44% above the sector average67.44% above the sector average67.44% above the sector average67.44% above the sector average67.44% above the sector average
Income
19.64% above the market average19.64% above the market average19.64% above the market average19.64% above the market average19.64% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Growth
41.70% above the market average41.70% above the market average41.70% above the market average41.70% above the market average41.70% above the market average
57.14% below the sector average57.14% below the sector average57.14% below the sector average57.14% below the sector average57.14% below the sector average

What The Brokers Say

Strong Buy 3
Buy 3
Neutral 13
Sell 2
Strong Sell 0
Total 21
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q3 Q2
Ex-Div 12-Nov-26 13-Aug-26
Paid 07-Jan-27 08-Oct-26
Amount 17.00p 17.00p

Trades for --2026

Time Volume / Share Price
0 @ 0.000p

GSK Key Personnel

CEO Luke Miels

Top of Page